BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20187803)

  • 1. Selective suicide gene therapy of colon cancer cell lines exploiting fibroblast growth factor 18 promoter.
    Teimoori-Toolabi L; Azadmanesh K; Zeinali S
    Cancer Biother Radiopharm; 2010 Feb; 25(1):105-16. PubMed ID: 20187803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter.
    Teimoori-Toolabi L; Azadmanesh K; Amanzadeh A; Zeinali S
    BioDrugs; 2010 Apr; 24(2):131-46. PubMed ID: 20199127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH; Song Y; Ma DX; Qu X; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
    Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytosine deaminase and thymidine kinase double suicide gene system driven by carcinoembryonic antigen promoter for the treatment of colorectal carcinoma xenograft in nude mice].
    Huang ZJ; Feng QZ; You J; Xu L; Luo WY; Yi WC; Zeng YY; Luo Q
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2235-40. PubMed ID: 24169337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of expression of survivin promoter-driven CD/TK double suicide genes by the nuclear matrix attachment region in transgenic gastric cancer cells.
    Niu Y; Li JS; Luo XR
    Gene; 2014 Jan; 534(2):177-82. PubMed ID: 24220851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
    Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
    Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of polyethylenimine-mediated transfection of suicide gene HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3].
    Jin P; Kong BH
    Ai Zheng; 2005 Jul; 24(7):806-11. PubMed ID: 16004805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
    Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M
    Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex.
    Shimokawa T; Furukawa Y; Sakai M; Li M; Miwa N; Lin YM; Nakamura Y
    Cancer Res; 2003 Oct; 63(19):6116-20. PubMed ID: 14559787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
    Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double suicide gene therapy with RNAi targeting to STAT3 inhibits the growth of colorectal carcinoma cells in vitro].
    Chen JY; Luo B; Guo XB; Wan LH
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):91-6. PubMed ID: 21575474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.
    Takeda T; Inaba H; Yamazaki M; Kyo S; Miyamoto T; Suzuki S; Ehara T; Kakizawa T; Hara M; DeGroot LJ; Hashizume K
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3531-8. PubMed ID: 12915632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.